Download JOHAN ASKLING PUBLICATIONS 2014 Peer-reviewed

JOHAN ASKLING PUBLICATIONS 2014
Peer-reviewed articles
1: Kearsley-Fleet L, Zavada J, Hetland ML, Nordström DC, Aaltonen KJ, Listing J, Zink A,
Gati T, Rojkovich B, Iannone F, Gremese E, van Riel PL, van de Laar MA, Lie E, Kvien TK,
Canh√£o H, Fonseca JE, Rotar Z, Loza E, Carmona L, Askling J, Johansson K, Finckh A,
Dixon WG, Hyrich KL; on behalf of the EULAR Study Group for Registers and
Observational Drug Studies. The EULAR Study Group for Registers and Observational Drug
Studies: comparability of the patient case mix in the European biologic disease modifying
anti-rheumatic drug registers. Rheumatology (Oxford). 2014 Nov 27. pii: keu446. [Epub
ahead of print] PubMed PMID: 25433042.
2: Jakobsen AK, Jacobsson LT, Patschan O, Askling J, Kristensen LE. Is nephrolithiasis an
unrecognized extra-articular manifestation in ankylosing spondylitis? A prospective
population-based Swedish national cohort study with matched general population comparator
subjects. PLoS One. 2014 Nov 25;9(11):e113602. doi: 10.1371/journal.pone.0113602.
eCollection 2014. PubMed PMID: 25423471.
3: Jiang X, Frisell T, Askling J, Karlson EW, Klareskog L, Alfredsson L, Källberg H. To
which extent may the familial risk of rheumatoid arthritis be explained by established RA
risk factors? Arthritis Rheumatol. 2014 Nov 24. doi:10.1002/art.38927. [Epub ahead of print]
PubMed PMID: 25418518.
4: Wadström H, Eriksson J, Neovius M, Askling J, On Behalf Of The Artis Study Group.
How good is the coverage and how accurate are exposure data in the Swedish Biologics
Register (ARTIS)? Scand J Rheumatol. 2014 Nov 7:1-7. [Epub ahead of print] PubMed
PMID: 25379815.
5: Eriksson JK, Askling J, Arkema EV. The Swedish Rheumatology Quality Register:
optimisation of rheumatic disease assessments using register-enriched data. Clin Exp
Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-147-9. Epub 2014 Oct 30. PubMed PMID:
25365105.
6: Fang F, Sveinsson O, Thormar G, Granqvist M, Askling J, Lundberg IE, Ye W,
Hammarström L, Pirskanen R, Piehl F. The autoimmune spectrum of myasthenia gravis: a
Swedish population-based study. J Intern Med. 2014 Sep 22. doi: 10.1111/joim.12310. [Epub
ahead of print] PubMed PMID: 25251578.
7: Raaschou P, Frisell T, Askling J; for the ARTIS Study Group; for the ARTIS Study Group.
TNF inhibitor therapy and risk of breast cancer recurrence in patients with rheumatoid
arthritis: a nationwide cohort study. Ann Rheum Dis. 2014 Aug 8. pii: annrheumdis-2014205745. doi: 10.1136/annrheumdis-2014-205745. [Epub ahead of print] PubMed PMID:
25107559.
8: Arkema EV, Feltelius N, Olsson T, Askling J; ARTIS study group. No association
between rheumatoid arthritis, amyotrophic lateral sclerosis, and tumour necrosis factor
inhibitor treatment. Ann Rheum Dis. 2014 Nov;73(11):2061-2. doi:10.1136/annrheumdis2014-205622. Epub 2014 Aug 5. PubMed PMID: 25096786.
9: Ljung L, Askling J, Rantapää-Dahlqvist S, Jacobsson L; ARTIS Study Group. The risk of
acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor
inhibitors and the risk in the general population: a national cohort study. Arthritis Res Ther.
2014 Jun 18;16(3):R127. doi: 10.1186/ar4584. PubMed PMID: 24941916; PubMed Central
PMCID: PMC4095691.
10: Holmes MD, Olsson H, Pawitan Y, Holm J, Lundholm C, Andersson TM, Adami HO,
Askling J, Smedby KE. Aspirin intake and breast cancer survival - a nation-wide study using
prospectively recorded data in Sweden. BMC Cancer. 2014 Jun 2;14:391. doi: 10.1186/14712407-14-391. PubMed PMID: 24890520; PubMed Central PMCID: PMC4065077.
11: Hellgren K, Smedby KE, Backlin C, Sundstrom C, Feltelius N, Eriksson JK, Baecklund
E, Askling J. Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a
cohort study based on nationwide prospectively recorded data from Sweden. Arthritis
Rheumatol. 2014 May;66(5):1282-90. doi:10.1002/art.38339. PubMed PMID: 24782185.
12: Sellgren C, Frisell T, Lichtenstein P, Landen M, Askling J. The association between
schizophrenia and rheumatoid arthritis: a nationwide population-based Swedish study on
intraindividual and familial risks. Schizophr Bull. 2014 Nov;40(6):1552-9. doi:
10.1093/schbul/sbu054. Epub 2014 Apr 8. PubMed PMID:24714379; PubMed Central
PMCID: PMC4193721.
13: Sparks JA, Chen CY, Jiang X, Askling J, Hiraki LT, Malspeis S, Klareskog L, Alfredsson
L, Costenbader KH, Karlson EW. Improved performance of epidemiologic and genetic risk
models for rheumatoid arthritis serologic phenotypes using family history. Ann Rheum Dis.
2014 Apr 30. doi: 10.1136/annrheumdis-2013-205009. [Epub ahead of print] PubMed PMID:
24685909.
14: Neovius M, Askling J. Response to: 'Drug survival on TNF inhibitors: 2003-2004 data
from Italian National Register (GISEA Register)' by Iannone et al. Ann Rheum Dis. 2014
Jun;73(6):e32. doi: 10.1136/annrheumdis-2013-205037. Epub 2014 Mar 17. PubMed PMID:
24638970.
15: Arkema EV, Jonsson J, Baecklund E, Bruchfeld J, Feltelius N, Askling J; on behalf of the
ARTIS Study Group. Are patients with rheumatoid arthritis still at an increased risk of
tuberculosis and what is the role of biological treatments? Ann Rheum Dis. 2014 Mar 7. doi:
10.1136/annrheumdis-2013-204960. [Epub ahead of print] PubMed PMID: 24608401.
16: Chatzidionysiou K, Askling J, Eriksson J, Kristensen LE, van Vollenhoven R; for the
ARTIS group. Effectiveness of TNF inhibitor switch in RA: results from the national
Swedish register. Ann Rheum Dis. 2014 Jan 15. doi:10.1136/annrheumdis-2013-204714.
[Epub ahead of print] PubMed PMID: 24431398.
17: Baecklund E, Smedby KE, Sutton LA, Askling J, Rosenquist R. Lymphoma development
in patients with autoimmune and inflammatory disorders--what are the driving forces? Semin
Cancer Biol. 2014 Feb;24:61-70. doi:10.1016/j.semcancer.2013.12.001. Epub 2013 Dec 10.
Review. PubMed PMID: 24333759.
18: Persson I, Granath F, Askling J, Ludvigsson JF, Olsson T, Feltelius N. Risks of
neurological and immune-related diseases, including narcolepsy, after vaccination with
Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up. J
Intern Med. 2014 Feb;275(2):172-90. doi:10.1111/joim.12150. Epub 2013 Nov 10. PubMed
PMID: 24134219.
19: Busch K, Ludvigsson JF, Ekström-Smedby K, Ekbom A, Askling J, Neovius M.
Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based
register study. Aliment Pharmacol Ther. 2014 Jan;39(1):57-68. doi:10.1111/apt.12528. Epub
2013 Oct 16. PubMed PMID: 24127738.
20: Zavada J, Dixon WG, Askling J; EULAR Study group on Longitudinal Observational
Registers and Drug Studies. Launch of a checklist for reporting longitudinal observational
drug studies in rheumatology: a EULAR extension of STROBE guidelines based on
experience from biologics registries. Ann Rheum Dis. 2014 Mar;73(3):628. doi:
10.1136/annrheumdis-2013-204102. Epub 2013 Sep 20. PubMed PMID: 24058015.
21: Di Giuseppe D, Wallin A, Bottai M, Askling J, Wolk A. Long-term intake of dietary
long-chain n-3 polyunsaturated fatty acids and risk of rheumatoid arthritis: a prospective
cohort study of women. Ann Rheum Dis. 2014 Nov;73(11):1949-53. doi:
10.1136/annrheumdis-2013-203338. Epub 2013 Aug 12. PubMed PMID: 23940215.
22: Olofsson T, Petersson IF, Eriksson JK, Englund M, Simard JF, Nilsson J-Ö, Geborek P,
Jacobsson LT, Askling J, Neovius M. Predictors of work disability during the first 3 years
after diagnosis in a national rheumatoid arthritis inception cohort. Ann Rheum Dis. 2014
May;73(5):845-53. doi:10.1136/annrheumdis-2012-202911. Epub 2013 Mar 21. PubMed
PMID: 23520035.